Definition of a Skp2-c-Myc Pathway to Expand Human Beta-cells

Shiwani Tiwari1, Chris Roel1, Mansoor Tanwir2

  • 1Diabetes Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

Scientific Reports
|July 7, 2016
PubMed

Insights

Type 2 diabetes (T2D) is linked to reduced human beta-cell proliferation. Skp2 protein enhances beta-cell expansion and regeneration in T2D by targeting c-Myc, offering a potential therapeutic strategy.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Molecular Medicine

Background:

  • Type 2 diabetes (T2D) is characterized by insulin resistance and diminished functional beta-cell mass.
  • Reduced beta-cell mass in T2D may result from developmental issues, impaired adaptive expansion, or beta-cell death/de-differentiation.

Purpose of the Study:

  • To investigate the hypothesis that human beta-cells from T2D donors exhibit a reduced proliferative response to mitogens.
  • To explore the role of cell cycle regulators in T2D beta-cell dysfunction and identify potential targets for beta-cell regeneration.

Main Methods:

  • Assessed the proliferative response of human beta-cells from T2D and non-diabetic donors to specific mitogens (cdk6 and cyclin D3).
  • Investigated the role of the cell cycle inhibitor p27(kip1) and the E3 ubiquitin ligase Skp2 in regulating beta-cell proliferation.
  • Utilized adenoviral delivery for gene manipulation and measured beta-cell expansion and proliferation rates.

Main Results:

  • Human beta-cells from T2D donors showed a significantly impaired proliferative response to cdk6 and cyclin D3.
  • Increased nuclear abundance of p27(kip1) was observed in T2D beta-cells, and its overexpression inhibited proliferation in non-diabetic beta-cells.
  • Skp2 overexpression, unlike p27(kip1) silencing, effectively promoted human beta-cell expansion and significantly enhanced T2D beta-cell proliferation.
  • c-Myc was identified as a key Skp2 target essential for initiating cell cycle entry and promoting beta-cell expansion and regeneration.

Conclusions:

  • The impaired proliferative capacity of beta-cells contributes to the pathogenesis of T2D.
  • Skp2 plays a critical role in beta-cell expansion and regeneration, potentially through c-Myc regulation.
  • Targeting the Skp2-c-Myc pathway represents a promising strategy for regenerating beta-cells in T2D.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.8K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K